- July 25: EMVO published an announcement reminding onboarding partners (OBPs) to confirm the correct entries for Designated Wholesalers in their product master data for each product.
- July 25: The latest draft version of the Normative Instruction circulated on July 13 mirrors Brazilian Law: All supply chain stakeholders (manufacturers, importers, wholesalers, dispensers (with the exclusion of national healthcare systems and clinics/health offices) are expected, beginning on April 28, 2022, to report all transactions on serialized products. All in-scope products are required to be serialized by this date. Next meeting of the ANVISA directors (DICOL) meeting is on August 4.
- July 25: Deadlines with Phase 1 medications appear to be set for November, 2022 based on the latest amendment. Traceability scope for this phase is 400 products in the public healthcare system (RPIS).
- July 25: Current information indicates phased implementation of traceability, with serialization for 93 products beginning in May, 2022 and reporting for that same product scope in January, 2023. The industry is seeking confirmation of this phased approach and consequent dates.
TraceLink is the world’s largest digital supply network for the pharmaceutical industry supply chain. It enables firms in the healthcare sector to achieve greater transparency, agility, and resiliency in pharma supply chains and enhance pharmaceutical supply chain security through real-time information and insights sharing. Providing firms in the pharma value chain with the tools and advanced capabilities they need to improve pharmaceutical supply chain management, TraceLink’s technology is powering the digital transformation of the global medical supply chain and accelerating pharmaceutical supply chain optimization. TraceLink helps pharmaceutical supply partners better manage and build flexibility and resilience into medical supply chains by providing them with innovative pharmaceutical supply chain solutions that help promote and foster communication, collaboration, and enduring strategic partnerships.